PubMed

Primary cutaneous aggressive epidermotropic CD8(+) T-cell lymphoma.

Gormley RH, Hess SD, Anand D, Junkins-Hopkins J, Rook AH, Kim EJ.

J Am Acad Dermatol. 2009 Nov 25. [Epub ahead of print]PMID: 19944484 [PubMed - as supplied by publisher]Related articles

Vorinostat for the treatment of bullous pemphigoid in the setting of advanced, refractory cutaneous T-cell lymphoma.

Gardner JM, Evans KG, Goldstein S, Kim EJ, Vittorio CC, Rook AH.

Arch Dermatol. 2009 Sep;145(9):985-8. No abstract available. PMID: 19770436 [PubMed - indexed for MEDLINE]Related articles

Extracorporeal photopheresis: past, present, and future.

Knobler R, Barr ML, Couriel DR, Ferrara JL, French LE, Jaksch P, Reinisch W, Rook AH, Schwarz T, Greinix H.

J Am Acad Dermatol. 2009 Oct;61(4):652-65. Epub 2009 Aug 7. Review.PMID: 19665258 [PubMed - indexed for MEDLINE]Related articles

A novel regimen of vorinostat with interferon gamma for refractory Sézary syndrome.

Gardner JM, Introcaso CE, Nasta SD, Kim EJ, Vittorio CC, Rook AH.

J Am Acad Dermatol. 2009 Jul;61(1):112-6.PMID: 19539845 [PubMed - indexed for MEDLINE]Related articles

Update on treatment of cutaneous T-cell lymphoma.

Gardner JM, Evans KG, Musiek A, Rook AH, Kim EJ.

Curr Opin Oncol. 2009 Mar;21(2):131-7. Review.PMID: 19532014 [PubMed - indexed for MEDLINE]Related articles

In vivo imaging of cutaneous T-cell lymphoma migration to the skin.

Hoeller C, Richardson SK, Ng LG, Valero T, Wysocka M, Rook AH, Weninger W.

Cancer Res. 2009 Apr 1;69(7):2704-8. Epub 2009 Mar 24.PMID: 19318575 [PubMed - indexed for MEDLINE]Related articles

CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement.

Introcaso CE, Kim EJ, Gardner J, Junkins-Hopkins JM, Vittorio CC, Rook AH.

Arch Dermatol. 2008 Aug;144(8):1027-9.PMID: 18711076 [PubMed - indexed for MEDLINE]Related articlesFree article

Gamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes.

Kasprzycka M, Zhang Q, Witkiewicz A, Marzec M, Potoczek M, Liu X, Wang HY, Milone M, Basu S, Mauger J, Choi JK, Abrams JT, Hou JS, Rook AH, Vonderheid E, Woetmann A, Odum N, Wasik MA.

J Immunol. 2008 Aug 15;181(4):2506-12.PMID: 18684941 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-alpha receptor.

Lin JH, Kim EJ, Bansal A, Seykora J, Richardson SK, Cha XY, Zafar S, Nasta S, Wysocka M, Benoit B, Rook AH, Fakharzadeh SS.

Blood. 2008 Sep 15;112(6):2484-8. Epub 2008 Jun 16.PMID: 18559673 [PubMed - indexed for MEDLINE]Related articlesFree article

Lethal vascular leak syndrome after denileukin diftitox administration to a patient with cutaneous gamma/delta T-cell lymphoma and occult cirrhosis.

Avarbock AB, Loren AW, Park JY, Junkins-Hopkins JM, Choi J, Litzky LA, Rook AH.

Am J Hematol. 2008 Jul;83(7):593-5.PMID: 18335564 [PubMed - indexed for MEDLINE]Related articles

Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression.

Contassot E, Kerl K, Roques S, Shane R, Gaide O, Dupuis M, Rook AH, French LE.

Blood. 2008 May 1;111(9):4780-7. Epub 2008 Feb 26.PMID: 18314443 [PubMed - indexed for MEDLINE]Related articlesFree article

Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells.

Marzec M, Halasa K, Kasprzycka M, Wysocka M, Liu X, Tobias JW, Baldwin D, Zhang Q, Odum N, Rook AH, Wasik MA.

Cancer Res. 2008 Feb 15;68(4):1083-91.PMID: 18281483 [PubMed - indexed for MEDLINE]Related articlesFree article

Stem cell transplantation in advanced cutaneous T-cell lymphoma.

Introcaso CE, Leber B, Greene K, Ubriani R, Rook AH, Kim EJ.

J Am Acad Dermatol. 2008 Apr;58(4):645-9. Epub 2008 Feb 6. Review.PMID: 18258335 [PubMed - indexed for MEDLINE]Related articles

Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndrome.

Introcaso CE, Micaily B, Richardson SK, Junkins-Hopkins JM, Yoon JS, Kim EJ, Vittorio CC, Rook AH.

J Am Acad Dermatol. 2008 Apr;58(4):592-5. Epub 2008 Feb 4.PMID: 18249469 [PubMed - indexed for MEDLINE]Related articles

Synthetic imidazoquinolines potently and broadly activate the cellular immune response of patients with cutaneous T-cell lymphoma: synergy with interferon-gamma enhances production of interleukin-12.

Wysocka M, Newton S, Benoit BM, Introcaso C, Hancock AS, Chehimi J, Richardson SK, Gelfand JM, Montaner LJ, Rook AH.

Clin Lymphoma Myeloma. 2007 Sep;7(8):524-34.PMID: 18021470 [PubMed - indexed for MEDLINE]Related articles

Progressive multifocal leukoencephalopathy from JC virus in a patient with advanced mycosis fungoides.

Lee J, Richardson SK, Melhem ER, Rook AH, Kim EJ.

J Am Acad Dermatol. 2007 Nov;57(5):893-5. Epub 2007 Aug 29.PMID: 17761357 [PubMed - indexed for MEDLINE]Related articles

IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndrome.

Yoon JS, Newton SM, Wysocka M, Troxel AB, Hess SD, Richardson SK, Lin JH, Benoit BM, Kasprzycka M, Wasik MA, Rook AH.

J Invest Dermatol. 2008 Feb;128(2):473-80. Epub 2007 Aug 23.PMID: 17713571 [PubMed - indexed for MEDLINE]Related articlesFree article

Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine.

Richardson SK, Newton SB, Bach TL, Budgin JB, Benoit BM, Lin JH, Yoon JS, Wysocka M, Abrams CS, Rook AH.

Am J Hematol. 2007 Sep;82(9):792-7.PMID: 17546636 [PubMed - indexed for MEDLINE]Related articles

Apoptotic responses to all-trans retinoic acid of targretin-resistant, malignant, CD4+ peripheral blood T cells from patients with Sezary syndrome.

Newton SB, Yoon JS, Benoit BM, Wysocka M, Rook AH.

Arch Dermatol. 2007 May;143(5):661-2. No abstract available. PMID: 17515523 [PubMed - indexed for MEDLINE]Related articles

Vision loss following denileukin diftitox treatment: a case report of possible posterior ischemic optic neuropathy.

Park M, Liu GT, Piltz-Seymour J, Wisda CL, Rook AH, Junkins-Hopkins JM, Nasta SD, Kim EJ.

Leuk Lymphoma. 2007 Apr;48(4):808-11. No abstract available. PMID: 17454642 [PubMed - indexed for MEDLINE]Related articles

High clinical response rate with multimodality immunomodulatory therapy for Sézary syndrome.

Richardson SK, Lin JH, Vittorio CC, Kim EJ, Yoon JS, Junkins-Hopkins J, Rook AH.

Clin Lymphoma Myeloma. 2006 Nov;7(3):226-32.PMID: 17229339 [PubMed - indexed for MEDLINE]Related articles

A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides.

Duvic M, Sherman ML, Wood GS, Kuzel TM, Olsen E, Foss F, Laliberté RJ, Ryan JL, Zonno K, Rook AH.

J Am Acad Dermatol. 2006 Nov;55(5):807-13. Epub 2006 Sep 8.PMID: 17052486 [PubMed - indexed for MEDLINE]Related articles

Mycosis fungoides and sezary syndrome: an update.

Kim EJ, Lin J, Junkins-Hopkins JM, Vittorio CC, Rook AH.

Curr Oncol Rep. 2006 Sep;8(5):376-86. Review.PMID: 16901399 [PubMed - indexed for MEDLINE]Related articles

A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis.

Knobler RM, French LE, Kim Y, Bisaccia E, Graninger W, Nahavandi H, Strobl FJ, Keystone E, Mehlmauer M, Rook AH, Braverman I; Systemic Sclerosis Study Group.

J Am Acad Dermatol. 2006 May;54(5):793-9.PMID: 16635659 [PubMed - indexed for MEDLINE]Related articles

Posttransplantation lymphoproliferative disease with features of lymphomatoid granulomatosis in a lung transplant patient.

Kwon EJ, Katz KA, Draft KS, Seykora JT, Rook AH, Wasik MA, Junkins-Hopkins JM.

J Am Acad Dermatol. 2006 Apr;54(4):657-63.PMID: 16546589 [PubMed - indexed for MEDLINE]Related articles

A role for regulatory T cells in cutaneous T-Cell lymphoma; induction of a CD4 + CD25 + Foxp3+ T-cell phenotype associated with HTLV-1 infection.

Walsh PT, Benoit BM, Wysocka M, Dalton NM, Turka LA, Rook AH.

J Invest Dermatol. 2006 Mar;126(3):690-2. No abstract available. PMID: 16410788 [PubMed - indexed for MEDLINE]Related articlesFree article

Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy.

Nebozhyn M, Loboda A, Kari L, Rook AH, Vonderheid EC, Lessin S, Berger C, Edelson R, Nichols C, Yousef M, Gudipati L, Shang M, Showe MK, Showe LC.

Blood. 2006 Apr 15;107(8):3189-96. Epub 2006 Jan 10.PMID: 16403914 [PubMed - indexed for MEDLINE]Related articlesFree article

CD8+ lymphoma in a patient with human immunodeficiency virus.

Hivnor CM, Nguyen V, Rook AH, Junkins-Hopkins J, Gelfand JM, Nasta S, Frank I, Kim EJ.

Arch Dermatol. 2005 Oct;141(10):1321-2. No abstract available. PMID: 16230579 [PubMed - indexed for MEDLINE]Related articles

Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing.

Nagasawa T, Zhang Q, Raghunath PN, Wong HY, El-Salem M, Szallasi A, Marzec M, Gimotty P, Rook AH, Vonderheid EC, Odum N, Wasik MA.

Leuk Res. 2006 Mar;30(3):303-12. Epub 2005 Sep 26.PMID: 16185764 [PubMed - indexed for MEDLINE]Related articles

The addition of interferon gamma to oral bexarotene therapy with photopheresis for Sézary syndrome.

McGinnis KS, Ubriani R, Newton S, Junkins-Hopkins JM, Vittorio CC, Kim EJ, Wysocka M, Rook AH.

Arch Dermatol. 2005 Sep;141(9):1176-8. No abstract available. PMID: 16172331 [PubMed - indexed for MEDLINE]Related articles

Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndrome.

Introcaso CE, Hess SD, Kamoun M, Ubriani R, Gelfand JM, Rook AH.

J Am Acad Dermatol. 2005 Sep;53(3):428-34.PMID: 16112348 [PubMed - indexed for MEDLINE]Related articles

Immunopathogenesis and therapy of cutaneous T cell lymphoma.

Kim EJ, Hess S, Richardson SK, Newton S, Showe LC, Benoit BM, Ubriani R, Vittorio CC, Junkins-Hopkins JM, Wysocka M, Rook AH.

J Clin Invest. 2005 Apr;115(4):798-812. Review. Erratum in: J Clin Invest. 2007 Mar;117(3):836. PMID: 15841167 [PubMed - indexed for MEDLINE]Related articlesFree article

Biological effects of bexarotene in cutaneous T-cell lymphoma.

Budgin JB, Richardson SK, Newton SB, Wysocka M, Zaki MH, Benoit B, Rook AH.

Arch Dermatol. 2005 Mar;141(3):315-21.PMID: 15781672 [PubMed - indexed for MEDLINE]Related articlesFree article

Low-dose bexarotene and low-dose interferon alfa-2b for adult T-cell leukemia/lymphoma associated with human T-lymphotropic virus 1.

Richardson S, Budgin JB, Junkins-Hopkins JM, Vittorio CC, Lee J, Miller WT Jr, Rook AH, Kim EJ.

Arch Dermatol. 2005 Mar;141(3):301-4. No abstract available. PMID: 15781670 [PubMed - indexed for MEDLINE]Related articlesFree article

Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15.

Wysocka M, Benoit BM, Newton S, Azzoni L, Montaner LJ, Rook AH.

Blood. 2004 Dec 15;104(13):4142-9. Epub 2004 Aug 24.PMID: 15328153 [PubMed - indexed for MEDLINE]Related articlesFree article

Impaired CD40L signaling is a cause of defective IL-12 and TNF-alpha production in Sézary syndrome: circumvention by hexameric soluble CD40L.

French LE, Huard B, Wysocka M, Shane R, Contassot E, Arrighi JF, Piguet V, Calderara S, Rook AH.

Blood. 2005 Jan 1;105(1):219-25. Epub 2004 Aug 17.PMID: 15315967 [PubMed - indexed for MEDLINE]Related articlesFree article

Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms.

McGinnis KS, Junkins-Hopkins JM, Crawford G, Shapiro M, Rook AH, Vittorio CC.

J Am Acad Dermatol. 2004 Mar;50(3):375-9.PMID: 14988678 [PubMed - indexed for MEDLINE]Related articles

Cytokine therapy of cutaneous T-cell lymphoma: interferons, interleukin-12, and interleukin-2.

Rook AH, Kuzel TM, Olsen EA.

Hematol Oncol Clin North Am. 2003 Dec;17(6):1435-48, ix. Review.PMID: 14710894 [PubMed - indexed for MEDLINE]Related articles

The use of cytokines, fusion proteins and antibodies to treat cutaneous T-cell lymphoma.

Rook AH, McGinnis KS, Richardson SK, Budgin JB, Wysocka M, Benoit BM, Hopkins JM, Vittorio CC.

Dermatol Ther. 2003;16(4):331-6. Review.PMID: 14686976 [PubMed - indexed for MEDLINE]Related articles

Eosinophilic fasciitis and eosinophilic cellulitis in a patient with abnormal circulating clonal T cells: increased production of interleukin 5 and inhibition by interferon alfa.

French LE, Shapiro M, Junkins-Hopkins JM, Wolfe JT, Rook AH.

J Am Acad Dermatol. 2003 Dec;49(6):1170-4.PMID: 14639411 [PubMed - indexed for MEDLINE]Related articles

Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma.

Richardson SK, McGinnis KS, Shapiro M, Lehrer MS, Kim EJ, Vittorio CC, Junkins Hopkins JM, Rook AH.

J Cutan Med Surg. 2003 Jul-Aug;7(4 Suppl):8-12. No abstract available. PMID: 12958701 [PubMed - indexed for MEDLINE]Related articles

Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen.

Shapiro M, Wasik MA, Junkins-Hopkins JM, Rook AH, Vittorio CC, Itakura H, Frankel MC, Georgala S, Schuster SJ.

Am J Hematol. 2003 Sep;74(1):46-51.PMID: 12949889 [PubMed - indexed for MEDLINE]Related articles

Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma.

McGinnis KS, Shapiro M, Vittorio CC, Rook AH, Junkins-Hopkins JM.

Arch Dermatol. 2003 Jun;139(6):771-5. Review.PMID: 12810509 [PubMed - indexed for MEDLINE]Related articlesFree article

Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma.

Kari L, Loboda A, Nebozhyn M, Rook AH, Vonderheid EC, Nichols C, Virok D, Chang C, Horng WH, Johnston J, Wysocka M, Showe MK, Showe LC.

J Exp Med. 2003 Jun 2;197(11):1477-88.PMID: 12782714 [PubMed - indexed for MEDLINE]Related articlesFree article

Extracorporeal photopheresis in the treatment of persistent rejection in a pediatric lung transplant recipient.

Wise BV, King KE, Rook AH, Mogayzel PJ Jr.

Prog Transplant. 2003 Mar;13(1):61-4.PMID: 12688651 [PubMed - indexed for MEDLINE]Related articles

Cytokines and other biologic agents as immunotherapeutics for cutaneous T-cell lymphoma.

Rook AH, Junkins-Hopkins JM, McGinnis KS, Wysocka M, Richardson SK, Budgin JB, Everitts S, Vittorio CC.

Adv Dermatol. 2002;18:29-43. Review.PMID: 12528401 [PubMed - indexed for MEDLINE]Related articles

Novel multimodality biologic response modifier therapy, including bexarotene and long-wave ultraviolet A for a patient with refractory stage IVa cutaneous T-cell lymphoma.

Shapiro M, Rook AH, Lehrer MS, Junkins-Hopkins JM, French LE, Vittorio CC.

J Am Acad Dermatol. 2002 Dec;47(6):956-61. No abstract available. PMID: 12451388 [PubMed - indexed for MEDLINE]Related articles

Sézary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines.

Wysocka M, Zaki MH, French LE, Chehimi J, Shapiro M, Everetts SE, McGinnis KS, Montaner L, Rook AH.

Blood. 2002 Nov 1;100(9):3287-94.PMID: 12384429 [PubMed - indexed for MEDLINE]Related articlesFree article

Identification of amplified clonal T cell populations in the blood of patients with chronic graft-versus-host disease: positive correlation with response to photopheresis.

French LE, Alcindor T, Shapiro M, McGinnis KS, Margolis DJ, Porter D, Leonard DG, Rook AH, Foss F.

Bone Marrow Transplant. 2002 Oct;30(8):509-15.PMID: 12379890 [PubMed - indexed for MEDLINE]Related articlesFree article

Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography in patients with cutaneous T- and B-cell lymphomas.

Shapiro M, Yun M, Junkins-Hopkins JM, Vittorio CC, Schulman N, Saidman BH, Fried RG, Rook AH, Alavi A.

J Am Acad Dermatol. 2002 Oct;47(4):623-8.PMID: 12271315 [PubMed - indexed for MEDLINE]Related articles